Agenda
10:00 - 10:05
Marius Trøseid and Johannes Hov Welcome
10:05 - 10:20
Andraz Nendl Intestinal fatty acid binding protein is associated with cardiac dysfunction and gut microbiota alterations in chronic heart failure
10:20 - 10:35
Jonas Lundekvam Proof of concept study; Probiotic intervention in patients with Ulcerative Colitis with insufficient response to anti-TNF treatment
10:35 - 10:50
Line Gaundal Replacing saturated fatty acids with polyunsaturated fatty acids increases the abundance of Lachnospiraceae and is associated with reduced total cholesterol levels - a randomized controlled trial in healthy individuals
10:50 - 11:20
Keynote Lecturer Peter Holger Johnsen Update on fecal microbiota transplantation: Where are we - where are we moving
11:20 - 11:45
Break
11:45 - 12:00
Petra Hradicka Human faecal microbiota transplant in mice (hFMT): how to increase the efficacy to resemble human microbiota composition?
12:00 - 12:15
Ida Rud Ratio-dependent effect of arabinoxylan and beta-glucan on microbiota and SCFAs during in vitro fermentation
12:15 - 12:30
Polona Rajar Microbial DNA extraction of high-host content and low biomass samples: optimized protocol for nasopharynx metagenomic studies
12:30 - 12:45
Warren Flood Development of a high-throughput qPCR platform for precise taxonomic characterization of the human gut microbiome
12:45 - 13:00
Silje Jørgensen Duodenal inflammation in Common variable immunodeficiency has altered transcriptional response to viruses
13:00 - 14:00
Lunch
14:00 - 14:45
Keynote Lecturer Fredrik Bäckhed Human Microbiome as a regulator of host physiology and metabolism
14:45 - 15:00
Break
15:00 - 15:15
Ekaterina Avershina Total neoplastic polyp volume is correlated to several bacterial taxa in faecal immunochemical test-positive CRC-screening patients
15:15 - 15:30
Paula Istvan Diverse virome in fecal immunochemical tests from bowel cancer screening participants
15:30 - 15:45
Christine Olbjørn Targeted microbiota profiling, for diagnosis, prognosis and treatment individualization in pediatric inflammatory bowel disease
15:45 - 16:00
Marius Trøseid and Johannes Hov Closing remarks